Halozyme Therapeutics, Inc. (HALO)

71.71 +1.28 (+1.82%) USD  |  NASDAQ  |  Jan 21, 16:00
71.71 0.00 (0.00%) After-Hours: 19:49
More

Halozyme Therapeutics Net Total Long Term Debt (Quarterly)

Net Total Long Term Debt (Quarterly) Chart

View Net Total Long Term Debt (Quarterly) for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Total Long Term Debt (Quarterly) Range, Past 5 Years

View Net Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Total Long Term Debt (Quarterly) Benchmarks

View Net Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Johnson & Johnson Upgrade
Merck & Co., Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Stryker Corp. Upgrade
Skye Bioscience, Inc. Upgrade